GLP-1 medications that suppress appetite are allowing people to better manage diabetes and obesity. As weight-loss drug ...

Idvynso is a new once-daily, two-drug oral regimen for adults with HIV-1 who are virologically suppressed and have no history ...

Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with ​type 2 diabetes, ...

ETHealthworld.com brings latest oxygen support news, views and updates from all top sources for the Indian Health industry.

Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...

The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections. By Dani Blum and Rebecca Robbins The Food and Drug Administration on Wednesday approved a ...

The change follows rising complaints about pharmacies refusing to cut tablet strips, forcing patients to buy extra medication. NEW DELHI: Patients may no longer be forced to buy an entire strip of ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

The pace of deployment of 5G standalone (5G+) networks across the UK has gone from strength to strength, with O2 raising the coverage bar by upgrading millions of customers in more than 700 towns and ...